Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.
暂无分享,去创建一个
Reinhard Bredehorst | Edzard Spillner | Mark Matzas | M. Matzas | Johanna Kölln | Nathalie Jänner | Thorsten Mix | Katrin Klensang | R. Bredehorst | E. Spillner | Johanna Kölln | Nathalie Jänner | Thorsten Mix | K. Klensang
[1] G. P. Smith,et al. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.
[2] A. Plückthun,et al. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.
[3] C. Alper,et al. Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement). , 1976, Science.
[4] H R Hoogenboom,et al. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. , 1991, Nucleic acids research.
[5] O. Götze,et al. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway , 1976, The Journal of experimental medicine.
[6] H. Müller-Eberhard,et al. Cobra venom factor: improved method for purification and biochemical characterization. , 1984, Journal of immunological methods.
[7] R. Harrison,et al. Structural characterization of factor I mediated cleavage of the third component of complement. , 1982, Biochemistry.
[8] M. Kock,et al. Structure and function of cobra venom factor, the complement-activating protein in cobra venom. , 1996, Advances in experimental medicine and biology.
[9] C. Cochrane,et al. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. , 1969, Journal of immunology.
[10] C. Silverman,et al. Heavy Chain Dimers as Well as Complete Antibodies Are Efficiently Formed and Secreted from Drosophila via a BiP-mediated Pathway (*) , 1995, The Journal of Biological Chemistry.
[11] B. Weintraub,et al. Expression of Biologically Active Human Thyrotropin (hTSH) in a Baculovirus System: Effect of Insect Cell Glycosylation on hTSH Activity in Vitro and in Vivo1. , 1997, Endocrinology.
[12] R. Bruccoleri,et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Lambris,et al. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. , 1988, The Journal of biological chemistry.
[14] H. Müller-Eberhard,et al. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. , 1982, The Journal of biological chemistry.
[15] H. Müller-Eberhard,et al. Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. , 1971, Journal of immunology.
[16] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .
[17] G. Winter,et al. Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.
[18] P. T. Jones,et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. , 1994, The EMBO journal.
[19] P. Lachmann,et al. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. , 1975, Clinical and experimental immunology.
[20] R. Possee. Cell-surface expression of influenza virus haemagglutinin in insect cells using a baculovirus vector. , 1986, Virus research.
[21] E. Petrella,et al. Immunoreactivity and function of oligosaccharides in cobra venom factor. , 1994, Journal of immunology.
[22] R. Frank,et al. Molecular interaction between the Strep-tag affinity peptide and its cognate target, streptavidin. , 1996, Journal of molecular biology.
[23] M. Paulsson,et al. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. , 1999, Clinical chemistry.
[24] R. Bredehorst,et al. Molecular cloning and derived primary structure of cobra venom factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[25] L. Caporale,et al. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. , 1988, The Journal of biological chemistry.
[26] Y. Okada,et al. TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.
[27] John D Lambris,et al. Overexpression, purification, and characterization of third component of complement. , 1994, Journal of immunological methods.
[28] C. Barbas,et al. Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. von Schaewen,et al. Molecular characterization of a novel glucose-6-phosphate dehydrogenase from potato (Solanum tuberosum L.). , 2000, The Plant journal : for cell and molecular biology.